4773.50
-0.18%
Motilal Oswal
domestic business grew robustly by 15% YoY to INR14.1b, led by channel refilling post GST. The company is expanding its presence in the domestic business via new product launches and expanding into new therapies. Alkem maintained its guidance for mid-teens growth in FY18; with channel refilling post GST, it is confident to achieve this target. Inventory levels are at ~30...
Alkem Laboratories Ltd. is trading below all available SMAs
More from Alkem Laboratories Ltd.
Recommended